Main Bile Duct Stricture Occurring After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Main Bile Duct Stricture Occurring After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Published:2010-01-08 Issue:6 Volume:33 Page:1168-1179
ISSN:0174-1551
Container-title:CardioVascular and Interventional Radiology
language:en
Short-container-title:Cardiovasc Intervent Radiol

Author:

Miyayama Shiro,Yamashiro Masashi,Okuda Miho,Yoshie Yuichi,Nakashima Yoshiko,Ikeno Hiroshi,Orito Nobuaki,Notsumata Kazuo,Watanabe Hiroyuki,Toya Daisyu,Tanaka Nobuyoshi,Matsui Osamu

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00270-009-9781-6.pdf

Reference26 articles.

1. Yamada R, Sato M, Kawabata M et al (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401

2. Takayasu K, Arri S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma. Gastroenterology 131:461–469

3. Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734–1739

4. Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171

5. Uchida H, Ohishi H, Matsuo N et al (1990) Transcatheter hepatic segmental arterial embolization using Lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol 13:140–145

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors and risk factors of bile duct injury after transcatheter arterial chemoembolization for hepatocellular carcinoma;BMC Cancer;2024-09-02

2. No lipiodol, no beads—another transcatheter arterial chemoembolization (TACE) with fine cisplatin powder and porous gelatin particles for TACE‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma;Cancer Medicine;2024-07

3. DEB‐TACE versus cTACE for unresectable HCC with B1‐type bile duct invasion after successful biliary drainage: A propensity score matching analysis;Cancer Medicine;2024-07

4. Transarterial Therapy for Hepatocellular Carcinoma Invading the Bile Duct;Interventional Radiology;2024-03-01

5. Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness;Cancers;2024-01-16